BASEL, Switzerland, Jan. 25, 2017 /PRNewswire/ -- Axovant Sciences (NYSE: AXON), a leading clinical-stage biopharmaceutical company focused on the treatment of dementia, today announced upcoming presentations at two investor conferences:
- February 16 at 1:30 p.m. EST at the Leerink Partners 6th Annual Global Healthcare Conference
- February 22 at 11:30 a.m. EST at the RBC Capital Markets 2017 Healthcare Conference
A simultaneous webcast will be available for each conference in the Investors section of Axovant's website at www.axovant.com. A replay will be available for 30 days following each conference.